Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-014287
Filing Date
2024-11-14
Accepted
2024-11-13 17:46:21
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q isdr_10q.htm   iXBRL 10-Q 1172122
2 CERTIFICATION isdr_ex311.htm EX-31.1 13205
3 CERTIFICATION isdr_ex312.htm EX-31.2 10479
4 CERTIFICATION isdr_ex32.htm EX-32 4366
  Complete submission text file 0001654954-24-014287.txt   5339115

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA celz-20240930.xsd EX-101.SCH 58166
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20240930_lab.xml EX-101.LAB 318846
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20240930_cal.xml EX-101.CAL 56296
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20240930_pre.xml EX-101.PRE 276889
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20240930_def.xml EX-101.DEF 171575
80 EXTRACTED XBRL INSTANCE DOCUMENT isdr_10q_htm.xml XML 778598
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 241455940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)